Samsung Healthcare acquires X startup Sonio

The result of mathematical research carried out at the Centre de Mathématiques Appliquées (CMAP*) in collaboration with Necker-Enfants Malades Hospital, Sonio aims to better detect possible congenital anomalies or rare diseases during fetal ultrasound, using artificial intelligence. Created in 2020, its acquisition by the medical subsidiary of Korean giant Samsung has just been finalized. While one out of every two congenital anomalies remains undetected using traditional fetal ultrasound methods, Sonio has developed a solution that supports the practitioner in carrying out antenatal diagnosis in real time, or after the examination to remove any doubt.